Kedi Bioscience Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
Kedi Bioscience General Information
Description
Developer of human-grade biologic therapies for pets, with a specialized focus on fully feline drug candidates designed to advance veterinary application and close the treatment gap in life-threatening and chronic diseases. The company obtains and analyzes clinical and molecular data about animal species' health and offers expertise in molecular biology and immunology, structural biology, bioinformatics, data and machine learning, biomedical and clinical research, enabling clients to discover biological drugs by leveraging data.
Contact Information
Website
www.kedi.bioCorporate Office
- Langegracht 70
- 2312 NV Leiden
- Netherlands
Corporate Office
- Langegracht 70
- 2312 NV Leiden
- Netherlands
Kedi Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue |
Kedi Bioscience FAQs
-
When was Kedi Bioscience founded?
Kedi Bioscience was founded in 2025.
-
Where is Kedi Bioscience headquartered?
Kedi Bioscience is headquartered in Leiden, Netherlands.
-
What industry is Kedi Bioscience in?
Kedi Bioscience’s primary industry is Other Services (B2C Non-Financial).
-
Is Kedi Bioscience a private or public company?
Kedi Bioscience is a Private company.
-
What is Kedi Bioscience’s current revenue?
The current revenue for Kedi Bioscience is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process